News of Group

R&D project of Wellhope Fame Biotechnology Co., Ltd. has been selected in Shenyang Science&Technology Innovation Project

Author: Source: Release Time: 2017-07-04 11:43:20 Browse: 241 Font Size:Big Middle Small

R&D project regarding to pathogenic entero becteria phage preparation conducted by Fame Biotechnology Co., Ltd., one of the wholly owned subsidiaries of Wellhope, and Korea CTCBIO company, has been selected in Shenyang Science&Technology Innovation Project --"Double Hundred" Significant Technical R&D Project.  

This new R&D project is aimed at treating pathogenic infectious diarrhea caused by drug resistant strain of intestinal bacteria, isolating specific phage, solving related critical problems such as antibiotic resistance and antibiotic residues. The two companies are dedicated to developing safe and efficient phage preparation, promoting the safety of animal products. 


丰美2.jpg

"Double Hundred" Project Certificate